title: Marimastat therapy as adjuvant to selective embolization in skeletal metastases of differentiated thyroid carcinoma.
authors.affiliation: Department of Endocrinology, Leiden University Medical Center, The Netherlands. j.w.a.smit.endo@lumc.nl
authors.forename: J W
authors.initials: JW
authors.lastname: Smit
authors.forename: K M
authors.initials: KM
authors.lastname: van Tol
authors.forename: J M
authors.initials: JM
authors.lastname: Hew
authors.forename: G J
authors.initials: GJ
authors.lastname: Vielvoye
authors.forename: J A
authors.initials: JA
authors.lastname: Romijn
authors.forename: T P
authors.initials: TP
authors.lastname: Links
mesh_terms: D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000556:secondary* / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D004621:Embolization, Therapeutic; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D008297:Male; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D008875:Middle Aged; D013964:Thyroid Neoplasms
chemical_list: D004791:Enzyme Inhibitors; D006877:Hydroxamic Acids; C100342:marimastat; D008666:Metalloendopeptidases